• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Retina Implant AG

Retina Implant wins CE Mark for next-gen blindness implant

March 30, 2016 By Brad Perriello

Retina Implant said today that it won CE Mark approval in the European Union for the latest iteration of its subretinal implant for patients blinded by retinitis pigmentosa. The Alpha AMS is the next-generation version of the Alpha IMS, which won CE Mark approval back in July 2013. The Reutlingen, Germany-based company said the new device increases the number […]

Filed Under: Optical/Ophthalmic, Regulatory/Compliance Tagged With: CE Mark, Retina Implant AG

Retina Implant drums up $28m

March 2, 2016 By Brad Perriello

Retina Implant said this week that it raised $28.2 million (€26 million) in private equity funding for its Alpha IMS device, which is designed to treat blind patients with retinitis pigmentosa. The round including contributions from new and existing backers, the Reutlingen, Germany-based company said. The proceeds are earmarked for new clinical centers and winning reimbursement in […]

Filed Under: Funding Roundup, Optical/Ophthalmic Tagged With: Alcon, Retina Implant AG, WaveLight Laser Technologies

Study: Retina Implant’s chip restores vision in blind patients

June 1, 2015 By Brad Perriello

Retina Implant AG, which is developing subretinal implants for patients blinded by retinitis pigmentosa, said a new study published in Vision Research shows positive results in patients treated with its Alpha IMS subretinal microchip. More than 86% of patients implanted with the device experienced improved ability to detect light and identify specific light sources, the […]

Filed Under: Business/Financial News, Optical/Ophthalmic Tagged With: Clinical Trials, Retina Implant AG

Retina Implant wins German reimbursement for vision-correcting microchip

August 11, 2014 By Arezu Sarvestani Leave a Comment

Retina Implant wins German reimbursement for vision-correcting microchip

Retina Implant AG announced this week that it won reimbursement from Germany’s government health system to cover the company’s flagship Alpha IMS microchip, an implantable device for helping to correct vision in patients with late-stage retinitis pigmentosa (RP).

The reimbursement win is Retina Implant’s 1st in the world, coming from the company’s home country.

Filed Under: News Well, Optical/Ophthalmic Tagged With: Retina Implant AG

Vision: Retina Implant AG wins E.U. approval for sight-restoring microchip

July 5, 2013 By Sony Salzman Leave a Comment

Retina Implant AG's Alpha IMS implant

European healthcare regulators this month granted CE Mark approval to Retina Implant AG’s Alpha IMS, a tiny eye implant that restores "useful" vision in patients blinded by retinitis pigmentosa.

Reutlingen, Germany-based Retina Implant AG, founded in 2003 from a German research institute spinout, touts the technology as "artificial sight." The Alpha IMS chip is implanted beneath the retina, where it sends electrical impulses to the brain to help restore visual capacity.

Filed Under: Implants, News Well, Optical/Ophthalmic Tagged With: CE Mark, Retina Implant AG, second-sight-medical

If you build a stent lab, they will come | MassDevice.com On Call

May 4, 2012 By MassDevice staff Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — A study of cardiac procedures in Michigan reveals a disrepancy between treatments, with areas hosting higher concentrations of catheterization labs performing more – and more expensive – stenting procedures than in areas with fewer labs.

In short, if you build a cath lab, they will come.

Filed Under: News Well, Stents Tagged With: Retina Implant AG

Diabetes: Medtronic wins clearance for next-gen clinical continuous glucose monitor | Regulatory Roundup

November 25, 2011 By MassDevice staff Leave a Comment

Medtronic logo

Medtronic Inc. (NYSE:MDT) won FDA clearance for its next generation iPro2 Professional continuous glucose monitor.

The iPro2 Professional is a clinician-owned device that collects glucose data from a sensor inserted into a patient’s skin.

The device tracks the patient’s glucose levels for 3 days, collecting data as many as 288 times each day. The information may provide insight into how diet, medication and daily activities affect a patient’s glucose levels.

Filed Under: News Well Tagged With: BSD Medical Corp., Canon, CerMed International, Clinical Trials, Dendreon Corp., Fujifilm, IntriCon Corp., IsoRay, Merz, neovasc, Regulatory Roundup, Retina Implant AG, STAAR Surgical Co, Translational Sciences Corp., Vascular Designs Inc.

Retina Implant touts findings on permanent eye implants | Research roundup

May 2, 2011 By MassDevice staff Leave a Comment

Clinical trials roundup

New data on patients implanted with a microchip designed to restore eyesight indicates that the device improved their vision enough to have an impact on their daily lives.

Retina Implant AG, the maker of a subrential implant designed to restore vision in people suffering from retinitus pigmentosa, said initial findings from the company’s second clinical trial showed that the first seven patients permanently implanted with the company’s device experienced restored useful visual function that enabled them to improve activities of daily living.

Filed Under: News Well, Optical/Ophthalmic, Research & Development Tagged With: Clinical Trials, Entellus Medical Inc., Retina Implant AG, stjudemedical

Topera Medical hires former Boston Scientific VP, opens Beantown HQ

March 18, 2011 By MassDevice staff Leave a Comment

Topera Medical

MASSDEVICE ON CALL — Topera Medical, a once-stealthy medical device start-up formerly based in San Diego, hired a former Boston Scientific Corp. (NYSE:BSX) vice president and moved clear across the country.

The firm, now based in Lexington, Mass., is looking to commercialize technology developed by Dr. Sanjiv Narayan at the University of California, San Diego. It hired former Boston Scientific VP Edward Kerslake to be its CEO in December 2010, according to Xconomy.

Filed Under: Diagnostics, Gynecological, News Well, Optical/Ophthalmic Tagged With: Cardiac Rhythm Management, GE Healthcare, Gen-Probe Inc., Photocure ASA, Retina Implant AG, Sagentia, Topera Medical

Retina Implant closes $18 million round | Funding roundup

March 3, 2011 By MassDevice staff Leave a Comment

Funding Roundup

Sub-retinal prosthesis developer Retina Implant AG raised $18 million in venture capital funding.

The company’s sub-retinal implant is comprised of a microchip that’s inserted into the eye to restore vision for people suffering from retinitis pigmentosa, a retinal degeneration disorder.

Filed Under: News Well, Optical/Ophthalmic Tagged With: BrainStorm Cell Therapeutics Inc., Nephros, Positron Corp., Retina Implant AG, Varian Medical Systems

MassDevice Podcast: Retina Implant CEO Walter Wrobel

December 9, 2010 By Christian Holland

Restoring vision to the blind is the sort of feat reserved for ancient religious texts and modern science fiction novels. But a company in Germany did just that with an eye implant.

Retina Implant AG is in the process of developing a sub-Retina Implant, designed to be inserted into the eye to treat back-of-the-eye disorders. A first clinical trial showed that the device can enable people suffering from a certain type of macular degeneration to see. The patients had retinitus pigmentosa, an inherited and incurable degenerative condition that causes tunnel vision and often, eventually, complete blindness. Retina Implant estimates that the condition affects about 200,000 people in the U.S. and Europe.

Filed Under: Business/Financial News, Device Talks Podcasts, Implants, News Well, Optical/Ophthalmic Tagged With: MassDevice Q&A, Podcast/Feature Tease, Retina Implant AG

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy